drugset / Trial / NCT04906109
Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of DA-2803 in Healthy Subjects
RandomizedCrossoverOpen-labelTreatment
Summary
This study is an open-label, randomized, single dose, crossover study to evaluate the pharmacokinetics, safety and tolerability of DA-2803 in healthy subjects
Timeline
- Start
- 2021-07-12
- Primary completion
- 2021-10-05
- Completion
- 2021-10-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DA-2803 | Unknown | — | — |
| Subject | tenofovir alafenamide | Small molecule | — | — |